JUL 12, 2016 8:19 AM PDT

Multiple Sclerosis, the Gut Microbiome & Potential Therapies

WRITTEN BY: Carmen Leitch
In 2010, researchers began to establish a link between diseases of the central nervous system and bacteria. It became more clear that it was the microbiome, the bacterial community that resides in the intestines of individuals, that was correlated with those types of diseases, and many other disorders as well including autoimmune dysfunction.
Multiple sclerosis, the signs and symptoms of which are discussed in the video above, is an autoimmune disease of the central nervous system, and scientists in the field began to investigate the relationship between it and gut bacteria. Researchers began to look in patients suffering from the disease to see how their microbiomes differed from healthy people, and while those differences were small in some cases, there were changes nonetheless.

A report in May 2016 in the European Journal of Neurology showed that there are different characteristics in the microbiomes of children with or without MS. Specific types of bacteria were present at varying amounts in children with multiple sclerosis compared to healthy children. In particular, it was found that multiple sclerosis was connected to an increase in gut bacteria linked to inflammation and a decrease in gut bacteria that are thought to be anti-inflammatory.
A new study in Scientific Reports has also reaffirmed that MS patients have a microbiome that is unlike that of people without MS. "Although preliminary, our data suggest that patients with MS have reduced levels of good bacteria responsible for overall benefits obtained from consuming healthy foods, such as soybean and flaxseeds," Ashutosh Mangalam, Assistant Professor of pathology at the University of Iowa Carver College of Medicine and senior author of the study.

"We identified certain bacteria which are increased or decreased in the gut of patients with MS compared to healthy controls," he continues.

In light of the increasing amount of evidence that not only links the microbioe with MS, but the characterization of that relationship, a new review article in the Journal of Interferon & Cytokine Research (JICR) has suggested that the microbiome could be a target for the prevention and treatment of MS.

Until August 6, 2016, the article is freely available on the JICR website. In it, coauthors Justin Glenn and Ellen Mowry of Johns Hopkins University School of Medicine present the various mechanisms by which several scenarios such as altered levels of bacteria in the human gut, bacteriophage activity, viral infections targeting bacteria, or bacterial toxins, could affect the immune system or possibly, play a role in causing autoimmune disorders like MS. Knowing more about the details of these mechanisms may help identify new drug targets or preventive strategies.

"This informative review presents the facts behind the notion that the nature of the intestinal microbial population may influence the development of autoimmune diseases, such as MS," explains Journal of Interferon & Cytokine Research Co-Editor-in-Chief Ganes C. Sen, of the Department of Immunology at Cleveland Clinic Foundation.
In the video above, Dr. Daniel Kantor speaks with Dr. Robert Herndon of the University of Mississippi Medical Center on the relationship between Microbiome and Multiple Sclerosis.

Sources: Khan AcademyEuropean Journal of NeurologyJournal of Interferon & Cytokine ResearchNature Scientific Reports
Sponsored by
About the Author
Bachelor's (BA/BS/Other)
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
Loading Comments...